Physician profile
John Rodgers
NPI 1184689473
$5,849.82
in general payments reported to CMS, 2019-2025
39 companies · $1,570 in 2025
The $1,570 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $287 · 2021: $320 · 2022: $679 · 2023: $986 · 2024: $1,374 · 2025: $1,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,929.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $992.27 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $789.57 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $461.87 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $420.65 | 2023-2025 | |
| Janssen Biotech, INC. | $303.77 | 2019-2025 | Erleada |
| Endo Pharmaceuticals INC. | $206.85 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $194.36 | 2024-2025 | Xiaflex |
| Abbvie INC. | $191.01 | 2024-2025 | |
| Pfizer INC. | $178.64 | 2022-2025 | |
| Urogen Pharma, INC. | $176.32 | 2022-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $166.95 | 2023-2025 | Pylarify |
| Ferring Pharmaceuticals INC. | $136.38 | 2019-2025 | Adstiladrin |
| Antares Pharma, INC. | $132.84 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Immunitybio, INC. | $132.71 | 2024-2025 | |
| Mission Pharmacal Company | $120.32 | 2019-2024 | Uribel Tabs, Uribel |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $100.31 | 2021-2024 | Rezum Generator |
| Myriad Genetic Laboratories, INC. | $94.27 | 2020-2023 | Prolaris |
| Medtronic, INC. | $90.95 | 2024-2025 | Interstim |
| Myovant Sciences INC. | $75.82 | 2021-2022 | |
| Convatec INC. | $73.13 | 2022 | |
| Merck Sharp & Dohme LLC | $71.20 | 2022-2023 | Keytruda, Lynparza |
| Teleflex LLC | $71.07 | 2024-2025 | Urolift |
| Tolmar, INC. | $70.34 | 2023-2025 | Jatenzo, Eligard |
| Coloplast Corp | $65.08 | 2022-2025 | Speedicath |
| Procept Biorobotics Corporation | $52.69 | 2024-2025 | Aquabeam System |
| Urovant Sciences INC | $51.35 | 2022 | |
| Sun Pharmaceutical Industries INC. | $45.53 | 2019 | |
| Telix Pharmaceuticals | $44.89 | 2023-2024 | Illuccix |
| Verity Pharmaceuticals INC. | $42.20 | 2021-2023 | Trelstar |
| Dentsply Ih Ab | $40.13 | 2023 | Lofric |
| Abc Home Medical Supply, INC. | $38.11 | 2022 | |
| Conmed Corporation | $37.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $36.56 | 2024-2025 | |
| 180 Medical, INC. | $27.82 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.78 | 2024 | Exparel |
| Olympus America INC. | $25.75 | 2025 | Itind System |
| Axonics, INC. | $23.19 | 2023 | Axonics |
| Braintree Laboratories, INC. | $22.77 | 2022 | |
| Curium US LLC | $18.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.